Electrophysiologic measure of endpoints for ablation lesions created in fibrillating substrates

Overview

Information

Number
6743225
Application
09/818206
Filing date
03/27/2001
Issue date
06/01/2004
Inventor(s)
Javier E. Sanchez, Jeffrey A. Hall, Michael E. Benser, Raymond E. Ideker, William M. Smith
US Classification
128/898; 606/32; 606/34; 606/41; 606/51; 607/101; 607/105
View at USPTO

Citations

Cardiac Pacemakers (25)
Edwards Lifesciences (2)
St. Jude Medical (1)
BioSense (1)
Engineering & Research Associates (1)
Heartport (1)
Boston Scientific (1)
AtriCure (1)

Abstract

Abstract

Methods, systems, and computer program products measure electrical activity of the cardiac tissue proximate the lesion site during an ablation treatment, and then compare the measurements to determine whether the lesion is clinically efficacious so as to be able to block myocardial propagation. The methods can include obtaining the measurements and performing the ablation therapy while the subject is experiencing atrial fibrillation and may measure the standard deviation of the electrogram signal.

Assignees with Similar Patents

The Johns Hopkins University (6)
St. Jude Medical (6)
Siemens (4)
Medtronic (4)
PaceSetter (4)

Referenced by

Covidien (102)
farapulse (29)
epix therapeutics (24)
Medtronic (17)
St. Jude Medical (17)
Boston Scientific (11)
ENDOPHOTONIX (8)
460MEDICAL, INC. (7)
George Washington University (7)
Maquet Cardiovascular, (5)
Mayo Foundation for Medical Education and Research (5)
aegis medical innovations (4)
AtriCure (4)
Biosense Webster (3)
MEDTRONIC ABLATION FRONTIERS TECHNOLOGIES, LLC (3)
University Of Iowa Research Foundation (3)
luxcath (2)
coral sand beach (2)
Baxter International (2)
SIEMENS HEALTHCARE GMBH (1)
iowa approach (1)
MEDTRONIC ALBATION FRONTIERS LLC (1)
Colorado State University Research Foundation (1)

Tech Analysis

Class Subclass Type Reference Factor Citation Factor Strength Grant time Early grant (%)
128 898 Emerging Sustaining Average Medium Average 68.7
606 32 Emerging Average Average Medium Average 58.5
606 34 Emerging Average Average Medium Average 51.1
606 41 Emerging Average Seminal Medium High Average 53.3
606 51 Emerging Average Seminal Medium High Average 52.0
607 101 Emerging Average Average Medium Average 60.8
607 105 Emerging Average Seminal Medium High Average 60.7